NEOLEUKIN THERAPEUTICS INC - COM (NLTX)

CUSIP: 64049K104

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
18,839,836
Share change
+18,839,836
Total reported value
$53,691,000
Price per share
$2.85
Number of holders
35
Value change
+$53,691,000
Number of buys
35

Quarterly Holders Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) as of Q3 2019

As of 30 Sep 2019, NEOLEUKIN THERAPEUTICS INC - COM (NLTX) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,839,836 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, Opaleye Management Inc., RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., and VANGUARD GROUP INC. This page lists 35 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.